Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Juvenile Bipolar Research Foundation (JBRF) is a non-profit organization dedicated to advancing the understanding and treatment of early-onset bipolar disorder. The foundation is recognized for its pioneering research into the 'Fear of Harm' phenotype, a distinct clinical profile characterized by sleep disturbances, thermoregulatory issues, and intense behavioral symptoms. JBRF supports and conducts clinical trials for innovative therapies, including the use of intranasal ketamine and light therapy, to address the specific biological drivers of the condition. By integrating genetic studies with clinical observation, the foundation aims to improve diagnostic precision and provide more effective, targeted interventions for children and their families. Their work also includes the development of standardized diagnostic tools used by clinicians worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juvenile Bipolar Research Foundation.